Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial-Reference-Cited by-同舟云学术

Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial

Published:2020-05 Issue:5 Volume:2 Page:e260-e269
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

van der Heijden Eefje Hanna Martine,Blokland Sofie Liny Marie,Hillen Maarten Reinier,Lopes Ana Paula Pinheiro,van Vliet-Moret Fréderique Marie,Rosenberg Antoine Johan Wilhelm Peter,Janssen Nard Gabriëlle,Welsing Paco Mattheus Jacobus,Iannizzotto Valentina,Tao Weiyang,Pandit Aridaman,Barone Francesca,Kruize Aike Albert,Radstake Timothy Ruben Dirk Jan,van Roon Joel Adrianus Gijsbert

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference22 articles.

1. Advances in understanding the pathogenesis of primary Sjögren's syndrome;Nocturne;Nat Rev Rheumatol,2013

2. Sjögren's syndrome;Mavragani;Annu Rev Pathol,2014

3. Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjögren's syndrome;Hillen;Expert Rev Clin Immunol,2014

4. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome;Theander;Ann Rheum Dis,2011

5. Optimizing conventional DMARD therapy for Sjögren's syndrome;van der Heijden;Autoimmun Rev,2018

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Sjögren disease syndrome;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Pathogenesis of Sjögren syndrome;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. Precision medicine in Sjögren's disease;The Lancet Rheumatology;2024-09

4. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study;The Lancet;2024-08

5. Physiopathologie (partie 2) – session « Rhumatologues en formation »;Revue du Rhumatisme;2024-08